GLP1R and diabetes mellitus: In this regard, molecules such as glucagon-like peptide 1 receptor agonists (GLP-1 RAs), dipeptidyl peptidase-4 inhibitors (DPP-4Is), and sodium-glucose co-transporter 2 inhibitors (SGLT-2Is), commonly used for diabetes treatment, showed promising results.